Etiological structure and comorbidity of cardioembolic stroke
https://doi.org/10.18705/1607-419X-2021-27-1-110-116
Abstract
Objective. Cardioembolic (CE) subtype has recently become increasingly important in the structure of brain stroke. This raises the question about the causes of CE stroke at the present stage. Clinical experience shows that the presence of comorbid disorders has a great influence on the course, early diagnosis, therapy and prognosis of the disease. However, the data on the structure of CE stroke and comorbid disorders are contradictory. This article aimed at studying etiological structure of CE stroke and its comorbidities.
Design and methods. The study included 62 patients at the acute phase of ischemic stroke aged from 44 to 96 years. The CHA2DS2-VASc scale was used to evaluate the expected annual stroke risk. Results. Our data show that the etiological structure of the CE stroke is presented predominantly by atrial fibrillation, followed by acute myocardial infarction. Compared to atherothrombotic stroke, the CE stroke was found to have a higher comorbidity index. CHA2DS2-VASc total score in patients with CE stroke showed a high risk of recurrent acute cerebrovascular accident.
Conclusions. Thus, an interdisciplinary approach to the diagnostic and treatment process involving a cardiologist and neurologist is required in order to improve the effectiveness of therapy and prognosis.
About the Authors
M. L. Chukhlovina
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Mariya L. Chukhlovina - MD, PhD, DSc, Professor, Department of Neurology and Psychiatry.
2 Akkuratova street, St Petersburg, 197341
T. M. Alekseeva
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Tat’ayna M. Alekseeva - MD, PhD, DSc, Associate Professor, Head, Department of Neurology and Psychiatry.
St Petersburg
E. S. Efremova
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Ekaterina S. Efremova - MD, Resident, Department of Neurology and Psychiatry.
St Petersburg
References
1. Shlyakhto EV, Zvartau NE, Villevalde SV, Yakovlev AN, Soloveva AE, Avdonina NG et al. Implemented models and elements for heart failure care in the regions of the Russian Federation: prospects for transformation into regional cardiovascular risk management systems. Russ J Cardiol. 2020;25(4):3792. doi:10.15829/1560-4071-2020-4-3792. In Russian.
2. Ionov MV, Zvartau NE, Konradi AO. First, look at new 2018 joint ESH/ESC Guidelines on diagnosis and management of hypertension. Arterial’naya Gipertenziya = Arterial Hypertension. 2018;24(3):351–358. doi:10.18705/1607-419X-2018-24-3-351-358. In Russian.
3. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.
4. Chen Z, Shi F, Zhang M, Gong X, Lin L, Lou M. Prediction of the multisegment clot sign on dynamic CT angiography of cardioembolic stroke. Am J Neuroradiol. 2018;39(4):663–668. doi:10.3174/ajnr.A5549
5. Park H-K, Lee JS, Hong KS, Cho YJ, Park J-M, Kang K et al. Statin therapy in acute cardioembolic stroke with no guidance-based indication. Neurology. 2020;12;94(19): e1984-e1995. doi:10.1212/WNL.0000000000009397
6. De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229. doi:10.1016/S0895-4356(02)00585–1
7. Kamel H, Healey JS. Cardioembolic stroke. Circ Res. 2017;120(3):514–526. doi:10.1161/CIRCRESAHA.116.308407
8. Patel AR, Patel AR, Desai S. The Underlying stroke etiology: a comparison of two classifications in a rural setup. Cureus. 2019;11(7): e5157. doi:10.7759/cureus.5157
9. Fernandez JS, Ortiz MR, Ballesteros FM, Luque CO, Penas ER, Ortega MD et al. CHA2DS2-VASc score as predictor of stroke and all-cause death in stable ischemic heart disease patients without atrial fibrillation. J Neurol. 2020;267(10):3061–3068. doi:10.1007/s00415-020-09961-7
10. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5): 373–383.
11. Pierik R, Algra A, van Dijk E, Erasmus ME, van Gelder IC, Koudstaal PJ et al. Distribution of cardioembolic stroke: A Cohort Study. Cerebrovasc Dis. 2020;49(1):97–104. doi:10.1159/000505616
12. Navis A, Garcia-Santibanez R, Skliut M. Epidemiology and outcomes of ischemic stroke and transient ischemic attack in the adult and geriatric population. J Stroke Cerebrovasc Dis. 2019;28(1):84–89.
13. Corraini P, Szépligeti SK, Henderson VW, Ording AG, Horváth-Puhó EE, Sørensen HT. Comorbidity and the increased mortality after hospitalization for stroke: A Population-Based Cohort Study. J Thromb Haemost. 2018;16(2):242–252. doi:10.1111/jth.13908
14. Abtan J, Bhatt DL, Elbez Y, Sorbets E, Eagle K, Ikeda Y. Residual ischemic risk and its determinants in patients with previous myocardial infarction and without prior stroke or TIA: Insights From the REACH Registry. Clin Cardiol. 2016;39(11):670–677. doi:10.1002/clc.22583
15. Ionin VA, Barashkova EI, Filatova AG, Baranova EI, Shlyakhto EV. Atrial fibrillation in St Petersburg cohort: frequency, risk factors, antiarrhythmic therapy and thromboembolism prevention. Arterial’naya Gipertenziya = Arterial Hypertension. 2020;26(2):192–201. doi:10.18705/1607-419X-2020-26-2-192-201. In Russian.
16. Khurshid S, Trinquart L, Weng L-C, Hulme OL, Guan W, Ko D et al. Atrial fibrillation risk and discrimination of cardioembolic from noncardioembolic stroke. Stroke. 2020;51(5):1396–1403. doi:10.1161/STROKEAHA.120.028837
17. Ferreira JP, Girerd N, Gregson J, Latar I, Sharma A, Pfeffer MA et al. Stroke risk in patients with reduced ejection fraction after myocardial infarction without atrial fibrillation. J Am Coll Cardiol. 2018;71(7):727–735. doi:10.1016/j.jacc.2017.12.011
18. Cipolla MJ, Liebeskind DS, Chan S-L. The Importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab. 2018;38(12):2129–2149. doi:10.1177/0271678X18800589
19. Damulin IV, Andreev DA, Salpagarova ZK. Cardioembolic stroke. Neurology, Neuropsychiatry, Psychosomatics. 2015;(1):80–86. doi:10.14412/2074-2711-2015-1-80-86. In Russian.
20. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013;15(5):625–651. doi:10.1093/europace/eut083
Supplementary files
Review
For citations:
Chukhlovina M.L., Alekseeva T.M., Efremova E.S. Etiological structure and comorbidity of cardioembolic stroke. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2021;27(1):110-116. (In Russ.) https://doi.org/10.18705/1607-419X-2021-27-1-110-116
Views:
855
Email this article 